David Krempa, Chief Business Officer at Eton Pharmaceuticals, Inc. (ETON), sold 25,000 shares at $65.07 ($1.6M) on 2026-08-24, disclosed to the SEC on 2026-08-24.
Open-market sale of $1.6M ETON by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ETON | SELL | 2025-06-16 | $908K | — | Filing → |